HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jiaxin Ye Selected Research

Long Noncoding RNA

1/2023LncRNA CASC2 Regulate Cell Proliferation and Invasion by Targeting miR-155/SOCS1 Axis in Hepatocellular Carcinoma.
1/2022Retraction notice to " LncRNA NEAT1 acts as a key regulator of cell apoptosis and inflammatory response by the miR-944/TRIM37 axis in acute lung injury'" [J. Pharmacol. Sci. 145 (2021) 202-212].
2/2021LncRNA NEAT1 acts as a key regulator of cell apoptosis and inflammatory response by the miR-944/TRIM37 axis in acute lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jiaxin Ye Research Topics

Disease

5Neoplasms (Cancer)
12/2023 - 11/2019
3Cachexia
12/2023 - 11/2021
2Acute Kidney Injury (Acute Renal Failure)
10/2023 - 11/2018
2Stroke (Strokes)
10/2023 - 11/2018
2Lung Neoplasms (Lung Cancer)
12/2022 - 11/2021
2Acute Lung Injury
01/2022 - 02/2021
2Infections
11/2018 - 09/2015
1Hypersensitivity (Allergy)
04/2024
1Asthma (Bronchial Asthma)
04/2024
1Chronic Disease (Chronic Diseases)
04/2024
1Atopic Dermatitis (Atopic Eczema)
04/2024
1Disease Progression
04/2024
1Hemorrhage
10/2023
1Pneumonia (Pneumonitis)
10/2023
1Bacteremia
10/2023
1Wound Infection (Wound Infections)
10/2023
1Delirium
10/2023
1Hepatocellular Carcinoma (Hepatoma)
01/2023
1Colonic Neoplasms (Colon Cancer)
12/2022
1Atrophy
12/2022
1Pathologic Processes
01/2022
1Heart Diseases (Heart Disease)
01/2022
1Lung Injury
02/2021
1Aortic Dissection
02/2021
1Renal Artery Obstruction (Renal Artery Stenosis)
01/2020
1Penetrating Atherosclerotic Ulcer
01/2020
1Aneurysm (Aneurysms)
01/2020
1Septic Shock (Toxic Shock Syndrome)
11/2018
1Atrial Fibrillation
11/2018
1Shock
11/2018
1Left Ventricular Dysfunction
11/2018
1Prostatic Neoplasms (Prostate Cancer)
12/2016
1Male Infertility (Male Sterility)
11/2015
1Urolithiasis
01/2015
1Carcinoma (Carcinomatosis)
01/2015
1Virus Diseases (Viral Diseases)
10/2014
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2012
1Myocardial Infarction
11/2012
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2012

Drug/Important Bio-Agent (IBA)

3Long Noncoding RNAIBA
01/2023 - 02/2021
3MicroRNAs (MicroRNA)IBA
11/2021 - 11/2019
2Conditioned Culture MediaIBA
12/2023 - 12/2022
2CytokinesIBA
12/2022 - 11/2012
2Circular RNAIBA
01/2022 - 11/2019
2Messenger RNA (mRNA)IBA
12/2019 - 09/2015
1Omalizumab (Xolair)FDA Link
04/2024
1Interleukin-8 (Interleukin 8)IBA
12/2022
1Leukemia Inhibitory FactorIBA
11/2021
1LipopolysaccharidesIBA
02/2021
1Norepinephrine (Noradrenaline)FDA LinkGeneric
11/2018
1Vasoconstrictor AgentsIBA
11/2018
1Vasopressins (Vasopressin)IBA
11/2018
1Superoxide DismutaseIBA
12/2016
1EnzymesIBA
11/2015
1Folic Acid (Vitamin M)FDA LinkGeneric
11/2015
1Proteins (Proteins, Gene)FDA Link
09/2015
1NucleoproteinsIBA
09/2015
1SulfotransferasesIBA
01/2015
1Protein Isoforms (Isoforms)IBA
01/2015
1ORALIT (ORS)IBA
01/2015
1Calcium-Sensing ReceptorsIBA
01/2015
1Single-Chain AntibodiesIBA
10/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2012
1ApelinIBA
11/2012
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2012
1integrin-linked kinaseIBA
01/2012

Therapy/Procedure

3Artificial Respiration (Mechanical Ventilation)
10/2023 - 11/2018
2Extracorporeal Membrane Oxygenation
10/2023 - 11/2018
1Length of Stay
10/2023
1Stents
01/2020